Aspirin resistance in patients with ischemic stroke

Aspirin resistance in patients with ischemic stroke

INTRODUCTION[|]Aspirin is the basic agent of antithrombotic treatment in ischemic cerebrovascular disease (CVD) patients. However several patients don't respond to treatment and therefore aspirin resistance term has been used lately. Recent studies have shown that aspirin resistance incidence i...

Full description

Bibliographic Details
Main Authors:	Anıl Bulut, Sultan Çağırıcı, Vildan Yayla, Murat Çabalar, Songül Şenadım
Format:	Article
Language:	English
Published:	KARE Publishing 2019-01-01
Series:	Southern Clinics of Istanbul Eurasia
Subjects:	ischemic stroke aspirin resistance multiplate analyzer
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=scie&un=SCIE-40427

Similar Items

Are Patients Getting Their Aspirin's Worth in Ischemic Stroke?
by: Alec A. Schmaier, et al.
Published: (2018-06-01)

Aspirin and clopidogrel resistance in Indian patients with ischemic stroke and its associations with gene polymorphisms: A pilot study
by: Samir Patel, et al.
Published: (2019-01-01)

Clinical Significance of Acute and Serial Platelet Function Testing in Acute Ischemic Stroke
by: Joon‐Tae Kim, et al.
Published: (2018-06-01)

Effect of aspirin resistance with dyslipidemia against VerifyNOWÂ® measurement in Bethesda hospital Yogyakarta
by: Hardi astuti witasari, et al.
Published: (2015-10-01)

Economic Evaluation of Ticagrelor Plus Aspirin Versus Aspirin Alone for Acute Ischemic Stroke and Transient Ischemic Attack
by: Jigang Chen, et al.
Published: (2022-03-01)

PENGARUH DIABETES MELLITUS TERHADAP RESISTENSI ASPIRIN PADA PASIEN STROKE ISKEMIK DI RUMAH SAKIT BETHESDA YOGYAKARTA
by: Hardi Astuti Witasari, et al.
Published: (2014-11-01)

Comparison of administration of clopidogrel with aspirin versus aspirin alone in prevention of secondary stroke after transient ischemic attack
by: Mojtaba Khazaei, et al.
Published: (2019-03-01)

Antiplatelet Resistance: A Review of Concepts, Mechanisms, and Implications for Management in Acute Ischemic Stroke and Transient Ischemic Attack
by: Kailash Krishnan, et al.
Published: (2023-05-01)

Genetic Association Study and Machine Learning to Investigate Differences in Platelet Reactivity in Patients with Acute Ischemic Stroke Treated with Aspirin
by: Anna Ikonnikova, et al.
Published: (2022-10-01)

Cerebral Microbleed Burden in Ischemic Stroke Patients on Aspirin: Prospective Cohort of Intracranial Hemorrhage
by: Chong-xi Xu, et al.
Published: (2021-10-01)

Aspirin for Primary Stroke Prevention; Evidence for a Differential Effect in Men and Women
by: Zuzana Gdovinova, et al.
Published: (2022-06-01)

Comparison of Different Laboratory Tests to Identify “Aspirin Resistance” and Risk of Vascular Events among Ischaemic Stroke Patients: A Double-Blind Study
by: Narayanaswamy Venketasubramanian, et al.
Published: (2022-05-01)

Aspirin resistance and blood biomarkers in predicting ischemic stroke recurrence: An exploratory study
by: PreranaDash, et al.
Published: (2022-01-01)

Efficacy and safety of lumbrokinase plus aspirin versus aspirin alone for acute ischemic stroke (LUCENT): study protocol for a multicenter randomized controlled trial
by: Ying Chen, et al.
Published: (2022-04-01)

Low-Molecular-Weight Heparin Versus Aspirin in Early Management of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
by: Hui Xia, et al.
Published: (2022-02-01)

Corrigendum: Low-molecular-weight heparin versus aspirin in early management of acute ischemic stroke: A systematic review and meta-analysis
by: Hui Xia, et al.
Published: (2022-11-01)

Antiplatelet Therapy in the Secondary Prevention of Non-cardioembolic Ischemic Stroke and Transient Ischemic Attack: A Mini-Review
by: Martin Vališ, et al.
Published: (2021-02-01)

Aspirin‐induced urticaria in a recently diagnosed ischemic stroke patient: A case report and literature review
by: Abhinav Dahal, et al.
Published: (2023-08-01)

Aspirin Resistance Affects Medium-Term Recurrent Vascular Events after Cerebrovascular Incidents: A Three-Year Follow-up Study
by: Adam Wiśniewski, et al.
Published: (2020-03-01)

Biochemical aspirin resistance in acute stroke patients and its association with clinical factors: a prospective pilot study
by: Michał Morton, et al.
Published: (2021-10-01)

The prevalence and associated factors of aspirin resistance among prophylactic aspirin users
by: Samaneh Ghorbani-Shirkouhi, et al.
Published: (2021-03-01)

Application of aspirin in the primary prevention of stroke
by: Zhao YANG, et al.
Published: (2015-02-01)

The benefit and safety of aspirin for primary prevention of ischemic stroke: a meta-analysis of randomized trials
by: Hong Lei, et al.
Published: (2016-11-01)

Effectiveness of Platelet Function Analysis-Guided Aspirin and/or Clopidogrel Therapy in Preventing Secondary Stroke: A Systematic Review and Meta-Analysis
by: Ann-Rong Yan, et al.
Published: (2020-12-01)

Precision medicine as a predictive factor for risk of hospitalization of recurrent ischemic stroke patients treated with low dose aspirin. A pilot study
by: Eman AlHussain A. Gawad, et al.
Published: (2023-12-01)

Dual Antiplatelet Therapy for the Acute Management and Long-term Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack, An Updated Review
by: Bernard P. L. Chan, et al.
Published: (2024-01-01)

Aspirin: yesterday, today, and tomorrow
by: Marina Nikołajewna Dołżenko
Published: (2014-06-01)

Analysis of antiplatelet therapy adherence in patients with ischemic cerebral stroke
by: Jie Zhong, et al.
Published: (2023-05-01)

Comparison Between Aspirin and Clopidogrel in Secondary Stroke Prevention Based on Real‐World Data
by: Nai‐Fang Chi, et al.
Published: (2018-10-01)

Multifactorial Background for a Low Biological Response to Antiplatelet Agents Used in Stroke Prevention
by: Adam Wiśniewski
Published: (2021-01-01)

Aspirin resistance: clinical and molecular genetic evaluation techniques
by: M. M. Tanashyan, et al.
Published: (2017-02-01)

Survey the Effect of Low Dose Aspirin on Serum Level of Uric Acid in Patients with Ischemic Heart Disease
by: Behzad Babapour, et al.
Published: (2012-11-01)

Decreased turnover aspirin resistance by bidaily aspirin intake and efficient cytoreduction in myeloproliferative neoplasms
by: Andréas Perrier-Cornet, et al.
Published: (2018-10-01)

Long Non-Coding RNA H19 Positively Associates With Aspirin Resistance in the Patients of Cerebral Ischemic Stroke
by: Jue Wang, et al.
Published: (2020-09-01)

ASPIRIN RESISTANCE AMONG PATIENTS WITH STABLE ISCHEMIC HEART DISEASE ASSESSED BY MEASUREMENT OF 11-DEHYDROTHROMBOXANE B2 IN URINE
by: Saad S. Hammadi, et al.
Published: (2012-06-01)

A Combination of Atorvastatin and Aspirin Enhances the Pro-Regenerative Interactions of Marrow Stromal Cells and Stroke-Derived Monocytes In Vitro
by: Nikunj Satani, et al.
Published: (2021-04-01)

Antithrombotic Therapy for Secondary Prevention in Patients with Non-Cardioembolic Stroke or Transient Ischemic Attack: A Systematic Review
by: Dániel Tornyos, et al.
Published: (2021-05-01)

TRUE RESISTANCE AND PSEUDORESISTANCE TO ASPIRIN
by: A. I. Martynov, et al.
Published: (2015-09-01)

Aspirin resistance and ischemic heart disease on Iranian experience
by: Masoumeh Sadeghi, et al.
Published: (2012-01-01)

Women With Osteoarthritis Are at Increased Risk of Ischemic Stroke: A Population-Based Cohort Study
by: Chung-Hsin Yeh, et al.
Published: (2021-12-01)